Adjuvant Vaccines Could Have Helped To Prevent H1N1 Shortfall, Industry Tells Congress
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has yet to approve adjuvanted influenza vaccines when they have been in use in Europe since 1997.
You may also be interested in...
Adjuvants Need Approval Pathway Separate From Vaccines, Industry Tells FDA
Industry is calling on FDA to write separate rules for assessing adjuvants. This would encourage innovation in immunotherapies, the Biotechnology Industry Organization and Pharmaceutical Research and Manufacturers of America contend.
Adjuvants Need Approval Pathway Separate From Vaccines, Industry Tells FDA
Industry is calling on FDA to write separate rules for assessing adjuvants. This would encourage innovation in immunotherapies, the Biotechnology Industry Organization and Pharmaceutical Research and Manufacturers of America contend.
Adjuvanted Flu Vaccines Get Booster: House Report Presses FDA On Approval
House appropriators are pressing FDA to license adjuvanted seasonal influenza vaccines that have a proven safety record.